Online lifestyle program for weight management and heart health
Tests a 90-day online exercise, supplement and education program in adults with heart risk factors.
Key facts
- Who runs it
- Truemedicine Inc
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
- Status
- Enrolling by invitation
- People taking part
- 200 people, planned
- Started
- 10 Apr 2026
- Planned end
- 1 Oct 2026
- Type of study
- Interventional
- Treatments tested
- Multicomponent Virtual Lifestyle Intervention
- Record updated
- 7 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 30 to 60 with a stable weight, a sedentary lifestyle and several heart-health risk signs. It runs fully online for 90 days.
- Age
- 30 to 60 years
- Sex
- All sexes can join.
- Disease stage
- At least 3 of 5 heart-health risk signs: large waist (35 inches or more for women, 40 inches or more for men), blood pressure 130/85 mmHg or higher, fasting glucose 100 mg/dL (5.6 mmol/L) or higher or HbA1c 5.7% (39 mmol/mol) or higher, triglycerides 150 mg/dL (1.7 mmol/L) or higher, low HDL cholesterol (below 40 mg/dL (1 mmol/L) for men, below 50 mg/dL (1.3 mmol/L) for women).
- Earlier treatment
- Must not be in any formal weight loss or weight management program. Weight change of no more than 5 pounds (2.3 kg) in the past 3 months.
Main reasons for not taking part
- Type 2 diabetes treated with medicine where unsupervised exercise could be risky
- Untreated, clinically significant sleep apnea where unsupervised exercise could be risky
- Taking investigational drugs or in another interventional study
- Pregnant or breastfeeding
- Unwilling to use Peloton equipment or get a Peloton digital membership
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adults aged 30 to 60 years at the time of enrollment Stable body weight, defined as no change of more than 5 pounds (2.3 kg) in the three months prior to enrollment Sedentary lifestyle, defined as fewer than 60 minutes of structured exercise per week Not currently participating in any formal weight loss or weight management program Current owner of at least one compatible wearable fitness or health tracking device (Garmin, Fitbit, Apple Watch, Oura Ring, or Whoop) Access to Peloton equipment or willingness to obtain a Peloton digital membership for the duration of the study Must meet the cardiovascular risk profile threshold (minimum of three of five criteria: waist circumference ≥35 inches (women) or ≥40 inches (men), most recent systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, most recent fasting glucose ≥100 mg/dL or HbA1c ≥5.7%, most recent triglycerides ≥150 mg/dL, most recent HDL cholesterol <40 mg/dL (men) or <50 mg/dL (women)) Able to read and understand English Willing to provide informed consent electronically Willing and able to complete all digital study activities, surveys, and assessments using the Alethios platform Willing and able to collect at-home dried blood spot (DBS) samples using a provided kit at three designated timepoints
Who cannot take part
- Diagnosis of type 2 diabetes requiring pharmacological management where participation in unsupervised exercise would pose risk, as determined by the investigator Untreated, clinically significant sleep apnea where unsupervised aerobic exercise participation could pose risk Any medical condition or circumstance that, in the opinion of the investigator, would make participation unsafe or interfere with data quality Unwillingness to use Peloton equipment or obtain a Peloton digital membership Current use of investigational drugs or participation in another interventional research study during the study period Pregnant or breastfeeding individuals Individuals unable to provide informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 60 years old?
Where in United States
- AlethiosSan Francisco, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This is a 90-day, single-arm, open-label, fully virtual community lifestyle intervention study evaluating the effects of a multicomponent lifestyle intervention on weight management and cardiovascular health. Participants will engage in structured aerobic exercise via the Peloton platform, take daily supplements (Omega-3, Vitamin D3, Magnesium Malate, and fiber), use wearable devices for activity and sleep tracking, and receive structured educational content. The study is conducted entirely remotely using the Alethios digital research platform.
The group in the trial
- Multicomponent Lifestyle InterventionTreatment being tested
Single arm receiving a 90-day multicomponent lifestyle intervention including structured aerobic exercise via Peloton platform, daily supplementation with Omega-3 (2400 mg/day), Vitamin D3 (4,000 IU/day), Magnesium Malate (440 mg/day), and fiber (6g/day), wearable-based activity and sleep tracking, and structured educational content.
Treatment: Multicomponent Virtual Lifestyle Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A 90-Day, Single-Arm, Open-Label, Fully Virtual Community Lifestyle Intervention Study Evaluating the Effects of a Multicomponent Lifestyle Intervention on Weight Management and Cardiovascular Health
- Plain-language title
- Online lifestyle program for weight management and heart healthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT07572721, who can take part
- Record updated
- 7 May 2026